Cardioprotection with phosphodiesterase-5 inhibitors: A novel preconditioning strategy

被引：0
|
作者：
Kukreja, RC [1 ]
机构：
[1] Virginia Commonwealth Univ, Med Ctr, Richmond, VA USA
来源：
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY | 2005年 / 38卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
122
引用
收藏
页码：853 / 853
页数：1
相关论文
共 50 条
  • [31] Pulmonary responses to selective phosphodiesterase-5 and phosphodiesterase-3 inhibitors
    Matot, I
    Gozal, Y
    CHEST, 2004, 125 (02) : 644 - 651
  • [32] Phosphodiesterase-5 inhibitors for the treatment of pulmonary arterial hypertension
    Beltran-Gamez, Miguel E.
    Sandoval-Zarate, Julio
    Pulido, Tomas
    ARCHIVOS DE CARDIOLOGIA DE MEXICO, 2015, 85 (03): : 215 - 224
  • [33] Co-prescription of phosphodiesterase-5 inhibitors and nitrates
    Scales, CD
    Curtis, LH
    Woosley, RG
    Springhart, WP
    Sur, RL
    Norris, RD
    Schulman, KA
    Donatucci, CF
    Albala, DM
    JOURNAL OF UROLOGY, 2005, 173 (04): : 199 - 199
  • [34] Do phosphodiesterase-5 inhibitors have a cardioprotective effect?
    Facio Junior, Fernando Nestor
    Azevedo Querichelli, Ana Flavia
    Santos, Bruno dos Reis
    Ferraz de Arruda, Germano Jose
    Fava Spessoto, Luis Cesar
    REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2020, 66 (11): : 1464 - 1465
  • [35] The role of phosphodiesterase-5 inhibitors in prostatic inflammation: a review
    Peixoto, Christina Alves
    dos Santos Gomes, Fabiana Oliveira
    JOURNAL OF INFLAMMATION-LONDON, 2015, 12
  • [36] Molecular Mechanisms of Phosphodiesterase-5 Inhibitors on Neuronal Apoptosis
    Duarte-Silva, Eduardo
    Peixoto, Christina Alves
    DNA AND CELL BIOLOGY, 2018, 37 (11) : 861 - 865
  • [37] Treatment of pulmonary arterial hypertension with phosphodiesterase-5 inhibitors
    Ghofrani, H. A.
    Grimminger, F.
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2006, 131 (49) : S311 - S314
  • [38] Pharmacodynamics, pharmacokinetics and clinical efficacy of phosphodiesterase-5 inhibitors
    Hong, Jeong Hee
    Kwon, Young Suk
    Kim, Isaac Yi
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2017, 13 (02) : 183 - 192
  • [39] The Treatment of Diabetic Genital Neuropathy by Phosphodiesterase-5 inhibitors
    Kurbatov, D.
    Rozbivanov, R.
    JOURNAL OF SEXUAL MEDICINE, 2009, 6 : 448 - 448
  • [40] Cardiac Effects of Phosphodiesterase-5 Inhibitors: Efficacy and Safety
    Sumon Roy
    Robert A. Kloner
    Fadi N. Salloum
    Ion S. Jovin
    Cardiovascular Drugs and Therapy, 2023, 37 : 793 - 806
12345